These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 1600389)

  • 21. [The role of immunization against bacterial enteric infections (author's transl)].
    Rey M
    Med Trop (Mars); 1979; 39(4):457-62. PubMed ID: 537492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera vaccines: fighting an ancient scourge.
    Mekalanos JJ; Sadoff JC
    Science; 1994 Sep; 265(5177):1387-9. PubMed ID: 8073279
    [No Abstract]   [Full Text] [Related]  

  • 24. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Infection; 1985; 13 Suppl 2():S206-10. PubMed ID: 3902655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herd protection and herd amplification in cholera.
    Sack DA
    J Health Popul Nutr; 2006 Mar; 24(1):1-5. PubMed ID: 16796143
    [No Abstract]   [Full Text] [Related]  

  • 28. The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
    Mayo-Smith LM; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Calderwood SB; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines for cholera control: does herd immunity play a role.
    von Seidlein L
    PLoS Med; 2007 Nov; 4(11):e331. PubMed ID: 18044982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of cholera and rise of novel mucosal vaccine.
    Yamamoto T
    Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.
    Chen WH; Cohen MB; Kirkpatrick BD; Brady RC; Galloway D; Gurwith M; Hall RH; Kessler RA; Lock M; Haney D; Lyon CE; Pasetti MF; Simon JK; Szabo F; Tennant S; Levine MM
    Clin Infect Dis; 2016 Jun; 62(11):1329-1335. PubMed ID: 27001804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.
    Suharyono ; Simanjuntak C; Witham N; Punjabi N; Heppner DG; Losonsky G; Totosudirjo H; Rifai AR; Clemens J; Lim YL
    Lancet; 1992 Sep; 340(8821):689-94. PubMed ID: 1355798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An oral B subunit: whole cell vaccine against cholera.
    Holmgren J; Svennerholm AM; Jertborn M; Clemens J; Sack DA; Salenstedt R; Wigzell H
    Vaccine; 1992; 10(13):911-4. PubMed ID: 1471411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CVD 103-HgR vaccine for travelers.
    Wong KK; Mahon BE; Reingold A
    Travel Med Infect Dis; 2016; 14(6):632-633. PubMed ID: 27693492
    [No Abstract]   [Full Text] [Related]  

  • 35. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P; Chaine JP; Johnson E; Hawley ML; O'Leary MJ; Oshitani H; Chaignat CL
    Vaccine; 2004 Jun; 22(19):2444-51. PubMed ID: 15193408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving immunization approaches to cholera.
    Saha A; Rosewell A; Hayen A; MacIntyre CR; Qadri F
    Expert Rev Vaccines; 2017 Mar; 16(3):235-248. PubMed ID: 27805467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral vaccines against cholera.
    Shin S; Desai SN; Sah BK; Clemens JD
    Clin Infect Dis; 2011 Jun; 52(11):1343-9. PubMed ID: 21498389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of cholera vaccines reassessed.
    Glass RI; Steele AD
    Lancet; 2005 Jul 2-8; 366(9479):7-9. PubMed ID: 15993211
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
    Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
    Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines.
    Ganguly R; Clem LW; Bencić Z; Sinha R; Sakazaki R; Waldman RH
    Bull World Health Organ; 1975; 52(3):323-30. PubMed ID: 779998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.